INCI · — · CIR review pending · used in 6 products
아세틸옥타펩타이드-3
ACETYL OCTAPEPTIDE-3
Evidence level
moderateEWG score
—Comedogenic
—Category
—● Benefits
Benefits to be documented.
● Cautions
No known cautions documented in the catalog.
Benefits to be documented.
No known cautions documented in the catalog.